FDA Approves Izervay (avacincaptad pegol) Intravitreal Solution for the Treatment for Geographic AtrophyTOKYO, Aug. 5, 2023 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President...
The California Institute for Regenerative Medicine (CIRM), the world’s largest institution dedicated to regenerative medicine, today awarded $50.1 million to fund clinical-stage research...
Mingozzi F, High KA. Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges. Nat Rev Genet. 2011;12:341–55.Article CAS PubMed ...
Milan-based biotech incubator Golgi Neurosciences is teaming up with Danish biopharma Breye Therapeutics to develop the P2X7 receptor antagonist programme for the treatment...
ARTICLE | Product DevelopmentPlus: BMS takes stake in Immatics and updates from Syndax, Incyte, Crescendo, Bavarian Nordic, Horizon, CERSI By BioCentury Staff
July 25, 2023 1:25 AM UTC
The...
The field of 3D bioprinting has emerged as a remarkable technological advancement in recent years. This revolutionary technique involves the fabrication of living tissues,...
Santhera Pharmaceuticals Holding has exclusively granted the rights to commercialise its Duchenne muscular dystrophy drug vamorolone in North America to Catalyst Pharmaceuticals...